ESMO 2022 – Why are some cancers so hard to treat?

Elena Riboldi — Agenzia Zoe | Conference Report | 13 September 2022

The discovery of features that give “born to be bad” cancers survival advantages is a fundamental step for the development of effective therapeutic options

Takeaway

The study of tumour heterogeneity explains why some cancers are especially aggressive and resistant to treatment.
Knowledge of tumour biology and clinical trial optimization will help to reduce hard-to-treat cancer mortality.

“Why is cancer the emperor of all maladies? One of the key answers is because cancer development is...

ESMO 2022 – Why are some cancers so hard to treat?

September Challenge

Long‐acting muscarinic antagonist/long‐acting beta‐agonist vs long‐acting beta‐agonist/inhaled corticosteroid: what is the risk for serious adverse events in stable chronic obstructive pulmonary disease?

Nasopharynx cancer: which therapy offers the highest survival rate?

What are the electrocardiogram findings in pulmonary hypertension?

What is the extent of the increased risk of progression of inflammatory bowel disease in iron deficiency anaemia?

Deep surgical site infection: what is the difference between single vs dual antibiotic load?

What is the primary risk factor for type 2 diabetes worldwide?

What are the risk factors for osteosarcopenia?

Is regular statin intake linked to a reduced rate of hepatocellular carcinoma?

Asymptomatic carotid stenosis: what are the recommended therapeutic options for carotid stenting?

Vertebral artery disease: what are the recommended imaging strategies?

What is the effect of metformin therapy on bone mineral density?

What are the risk factors associated with interstitial lung disease in patients with rheumatoid arthritis?

Is there an increased risk for ovarian cancer in postmenopausal women with polycystic ovary syndrome?

What are the physiological reactions of chromium in the body?

How do you manage acute coronary syndrome in patients receiving anticancer therapy?

What is the association between drugs approved for weight management and cardiovascular mortality?

What do you know about breast milk and its nutritional quantity?

Is there a lifetime increased risk for breast cancer in patients with meningioma?

Does vitamin D level influence colorectal cancer outcomes?

What are the effects of the COVID-19 pandemic and the incidence of diabetes in children?

Fluoroquinolones: what are the latest updates from the European Medicines Agency?

What are the special considerations for the management of atopic eczema?

Is maternal obsessive-compulsive disorder linked to adverse neonatal outcomes?

Does early live attenuated measles/mumps/rubella vaccine lower infection-related hospitalisation in infants?

What is the effect of bariatric surgery on colorectal cancer risk in patients with obesity?

What are the effects of anticoagulation therapy on atrial fibrillation patients with prior intracranial haemorrhage?

Topic Challenges

Quiz challenge Emerging diseases: COVID-19

ESMO 2020 topic challenge

Women's health challenge

Antibiotics - Consequence of MDR carriage

Neurological disorders challenge

Rheumatology challenge

Lyme Disease

Mental health challenge

Topic challenge - Children conditions

Lyme Disease